• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery.伽玛刀放射外科治疗非典型脑膜瘤后的失败模式。
J Neurooncol. 2012 May;108(1):179-85. doi: 10.1007/s11060-012-0828-1. Epub 2012 Feb 23.
2
Patterns of recurrence after stereotactic radiosurgery for treatment of meningiomas.立体定向放射外科治疗脑膜瘤后的复发模式。
Neurosurg Focus. 2013 Dec;35(6):E14. doi: 10.3171/2013.8.FOCUS13283.
3
Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study.伽玛刀放射外科治疗鞍区和鞍旁脑膜瘤:一项多中心研究。
J Neurosurg. 2014 Jun;120(6):1268-77. doi: 10.3171/2014.2.JNS13139. Epub 2014 Mar 28.
4
Role of gamma knife radiosurgery for recurrent or residual World Health Organization grade II and III intracranial meningiomas.伽玛刀放射外科治疗世界卫生组织二级和三级复发性或残留性颅内脑膜瘤的作用。
Br J Neurosurg. 2020 Jun;34(3):239-245. doi: 10.1080/02688697.2020.1726285. Epub 2020 Feb 13.
5
Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.伽玛刀放射外科治疗颅内良性脑膜瘤:130 例患者的随访结果。
Neurosurg Focus. 2019 Jun 1;46(6):E7. doi: 10.3171/2019.3.FOCUS1956.
6
Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.二级脑膜瘤和伽玛刀放射外科:提高治疗模式的成功与失败分析。
J Neurosurg. 2016 Dec;125(Suppl 1):89-96. doi: 10.3171/2016.7.GKS161521.
7
Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2.伽玛刀放射外科治疗2型神经纤维瘤病患者的脑膜瘤。
J Neurosurg. 2015 Mar;122(3):536-42. doi: 10.3171/2014.10.JNS132593. Epub 2015 Jan 2.
8
Efficacy and Safety of Gamma Knife Radiosurgery for Meningiomas in Patients with Neurofibromatosis Type 2: A Long-Term Follow-Up Single-Center Study.神经纤维瘤病 2 型患者伽玛刀放射外科治疗脑膜瘤的疗效和安全性:一项长期随访的单中心研究。
World Neurosurg. 2019 May;125:e929-e936. doi: 10.1016/j.wneu.2019.01.211. Epub 2019 Feb 11.
9
Dose-Response Relationships for Meningioma Radiosurgery.脑膜瘤放射外科的剂量-反应关系
Am J Clin Oncol. 2015 Dec;38(6):600-4. doi: 10.1097/COC.0000000000000008.
10
Gamma Knife Radiosurgery for Atypical and Anaplastic Meningiomas.伽玛刀放射外科治疗非典型和间变性脑膜瘤
World Neurosurg. 2016 Mar;87:557-64. doi: 10.1016/j.wneu.2015.10.021. Epub 2015 Oct 17.

引用本文的文献

1
Repeated stereotactic radiosurgery for high grade meningioma.复发性高级别脑膜瘤的立体定向放射外科治疗
J Neurooncol. 2025 Aug 13. doi: 10.1007/s11060-025-05165-z.
2
Toxicities Associated with Adjuvant Radiation Therapy in Atypical Meningioma.非典型脑膜瘤辅助放疗相关的毒性反应
Adv Radiat Oncol. 2025 Jan 25;10(3):101726. doi: 10.1016/j.adro.2025.101726. eCollection 2025 Mar.
3
Exploring the Role of Radiosurgery for Atypical Meningiomas: Addressing Suboptimal Local Control in High-Risk Patients.探索放射外科治疗非典型脑膜瘤的作用:解决高危患者局部控制欠佳的问题
Adv Radiat Oncol. 2025 Jan 30;10(3):101709. doi: 10.1016/j.adro.2024.101709. eCollection 2025 Mar.
4
The Impact of Molecular and Genetic Analysis on the Treatment of Patients with Atypical Meningiomas.分子与基因分析对非典型脑膜瘤患者治疗的影响
Diagnostics (Basel). 2024 Aug 15;14(16):1782. doi: 10.3390/diagnostics14161782.
5
Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis.II级和III级脑膜瘤的放射外科治疗:系统评价和荟萃分析
J Pers Med. 2024 Jul 29;14(8):802. doi: 10.3390/jpm14080802.
6
Topographic Patterns of Intracranial Meningioma Recurrences-Systematic Review with Clinical Implication.颅内脑膜瘤复发的地形学模式——具有临床意义的系统评价
Cancers (Basel). 2024 Jun 19;16(12):2267. doi: 10.3390/cancers16122267.
7
Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery.Ki-67 标记指数可预测立体定向放射外科治疗后非典型脑膜瘤患者的肿瘤进展模式和生存情况。
J Neurooncol. 2024 Mar;167(1):51-61. doi: 10.1007/s11060-023-04537-7. Epub 2024 Feb 18.
8
Frontiers of Cranial Base Surgery: Integrating Technique, Technology, and Teamwork for the Future of Neurosurgery.颅底外科前沿:融合技术、科技与团队合作,共创神经外科未来。
Brain Sci. 2023 Oct 23;13(10):1495. doi: 10.3390/brainsci13101495.
9
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.脑膜瘤放射治疗靶区勾画:ANOCEF 共识指南。
Radiat Oncol. 2023 Jul 5;18(1):113. doi: 10.1186/s13014-023-02300-w.
10
Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.放射治疗和立体定向放射外科作为非典型和间变性(世界卫生组织II级和III级)脑膜瘤辅助或挽救性治疗的疗效:一项系统评价和荟萃分析。
Neurosurg Rev. 2023 Mar 17;46(1):71. doi: 10.1007/s10143-023-01969-7.

本文引用的文献

1
Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.质子与光子适形放疗联合治疗颅内非典型及恶性脑膜瘤。
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):399-406. doi: 10.1016/j.ijrobp.2008.10.053. Epub 2009 Feb 7.
2
Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.非典型脑膜瘤在接受全切除术后无论是否进行术后辅助放疗的长期复发率。
Neurosurgery. 2009 Jan;64(1):56-60; discussion 60. doi: 10.1227/01.NEU.0000330399.55586.63.
3
Radiosurgery as definitive management of intracranial meningiomas.放射外科作为颅内脑膜瘤的确定性治疗方法。
Neurosurgery. 2008 Jan;62(1):53-8; discussion 58-60. doi: 10.1227/01.NEU.0000311061.72626.0D.
4
Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.非典型和恶性脑膜瘤:119例接受放疗患者的结局及预后因素。罕见癌症网络的多中心回顾性研究。
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1388-93. doi: 10.1016/j.ijrobp.2007.12.020. Epub 2008 Mar 4.
5
Stereotactic radiosurgery for atypical and anaplastic meningiomas.非典型性和间变性脑膜瘤的立体定向放射外科治疗
J Neurooncol. 2007 Aug;84(1):41-7. doi: 10.1007/s11060-007-9338-y. Epub 2007 Mar 15.
6
Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity.脑膜瘤的立体定向放射治疗:症状学、急性和晚期毒性。
Strahlenther Onkol. 2006 Jul;182(7):382-8. doi: 10.1007/s00066-006-1535-7.
7
Gamma knife surgery for atypical meningiomas.非典型脑膜瘤的伽玛刀手术
J Neurosurg. 2005 Jan;102 Suppl:283-6. doi: 10.3171/jns.2005.102.s_supplement.0283.
8
Meningiomas.脑膜瘤
Lancet. 2004 May 8;363(9420):1535-43. doi: 10.1016/S0140-6736(04)16153-9.
9
The effect of radiosurgery during management of aggressive meningiomas.放射外科手术在侵袭性脑膜瘤治疗中的作用。
Surg Neurol. 2003 Oct;60(4):298-305; discussion 305. doi: 10.1016/s0090-3019(03)00320-3.
10
Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients.脑膜瘤的放射外科治疗:190例连续患者的肿瘤控制、治疗结果及并发症
Neurosurgery. 2001 Nov;49(5):1029-37; discussion 1037-8. doi: 10.1097/00006123-200111000-00001.

伽玛刀放射外科治疗非典型脑膜瘤后的失败模式。

Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery.

机构信息

Department of Radiation Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.

出版信息

J Neurooncol. 2012 May;108(1):179-85. doi: 10.1007/s11060-012-0828-1. Epub 2012 Feb 23.

DOI:10.1007/s11060-012-0828-1
PMID:22359231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3794718/
Abstract

Atypical meningiomas have poor local control with emerging literature indicating the use of radiosurgery in treatment. The purpose of this study was to evaluate clinical outcomes including local control and failure pattern after Gamma Knife radiosurgery (GKRS) and factors that may affect these outcomes. Between 1999 and 2008, 24 patients were treated with GKRS as either primary or salvage treatment for pathologically proven atypical meningiomas. Treatment failures were determined by serial magnetic resonance imaging. A median marginal dose of 14 Gy was used (range 10.5-18 Gy). Overall local control rates at 1, 2, and 5 years were 75, 51, and 44%, respectively. With median follow-up time of 42.5 months, 14 of 24 patients experienced a treatment failure at time of last follow-up. Eight recurrences were in-field, four were marginal failures, and two were distant failures. Wilcoxon analysis revealed that the conformality index (CI) was a significant predictor of local recurrence (P = 0.04). CI did not predict for distant recurrences (P = 0.16). On multivariate analysis evaluating factors predicting progression free survival, dose >14 Gy was found to be statistically significant (P = 0.01). There appears to be a dose response using GKRS beyond 14 Gy but given the suboptimal local control rates in this study, higher doses may still be needed to obtain better local control.

摘要

非典型脑膜瘤局部控制效果不佳,越来越多的文献表明放射外科治疗的应用。本研究的目的是评估伽玛刀放射外科治疗(GKRS)后的临床结果,包括局部控制和失败模式,以及可能影响这些结果的因素。1999 年至 2008 年间,24 例经病理证实的非典型脑膜瘤患者接受 GKRS 作为一线或挽救性治疗。通过连续磁共振成像确定治疗失败。中位边缘剂量为 14 Gy(范围 10.5-18 Gy)。1、2、5 年的总体局部控制率分别为 75%、51%和 44%。中位随访时间为 42.5 个月,24 例患者中有 14 例在最后一次随访时出现治疗失败。8 例复发在照射野内,4 例为边缘失败,2 例为远处失败。Wilcoxon 分析显示适形指数(CI)是局部复发的显著预测因子(P = 0.04)。CI 对远处复发没有预测作用(P = 0.16)。多因素分析评估无进展生存的预测因素时,发现剂量>14 Gy 具有统计学意义(P = 0.01)。在超过 14 Gy 时,GKRS 似乎存在剂量反应,但考虑到本研究中局部控制率不理想,可能仍需要更高的剂量以获得更好的局部控制。